Core Insights - The plastic production in Jiangsu Province for June 2025 reached 1.084 million tons, showing a year-on-year growth of 0.4%, which is a significant slowdown of 16.8 percentage points compared to the same period last year [1] - For the first half of 2025, the total plastic production in Jiangsu Province was 6.38 million tons, reflecting a year-on-year increase of 6.7%, but this growth rate is 0.1 percentage points lower than the previous year [3] Production Data Analysis - In June 2025, Jiangsu's plastic production accounted for 9.0% of the national total of 12.032 billion tons, indicating a lower growth rate compared to the national average by 11.7 percentage points [1] - The cumulative plastic production from January to June 2025 represented 9.1% of the national total of 70.123 billion tons, with a growth rate lagging behind the national average by 3.6 percentage points [3] Historical Context - The term "primary plastic" was previously referred to as "plastic resin and copolymers" before 2004, indicating a shift in terminology within the industry [4] - Since 2011, the threshold for large-scale industrial enterprises in China has been raised from an annual main business income of 5 million yuan to 20 million yuan, reflecting changes in industry standards [4]

Core Viewpoint - The Chinese Ministry of Commerce expresses strong opposition to Mexico's recent anti-dumping investigations against Chinese products, emphasizing the need to adhere to WTO rules and protect the rights of Chinese enterprises [1][3]. Group 1: Anti-Dumping Investigations - Mexico has initiated four anti-dumping investigations against Chinese products including float glass, self-adhesive tape, PVC coated cloth, and steel bolts, following requests from domestic companies [1][3]. - This year, Mexico has launched a total of 11 anti-dumping investigations against Chinese products, nearly double the total from the previous year [1][3]. Group 2: Trade Relations and Responses - The Chinese side has been cautious and restrained in initiating trade remedy investigations, contrasting with the increasing number of investigations from Mexico [1][3]. - In response to Mexico's proposed increase in import tariffs and other trade restrictions, the Chinese Ministry of Commerce has initiated an investigation into trade and investment barriers [1][3]. - The Chinese government will take necessary measures across trade and investment sectors based on the investigation results to protect the legitimate rights of enterprises [1][3].

Group 1 - Double-Helix Pharmaceutical announced that its associate, Changfeng Pharmaceutical, is expected to be listed on the Hong Kong Stock Exchange on October 8, 2025, with a global offering of 41.198 million shares priced at HKD 14.75 each. Double-Helix holds approximately 3.68% of Changfeng's shares, with a lock-up period of 12 months post-listing [1] - Changfeng Pharmaceutical is involved in the pharmaceutical industry, specifically in the research and development of gene-engineered drugs [2] Group 2 - Lio Corporation has submitted an application to the Hong Kong Stock Exchange for issuing H-shares and listing on the main board [3] - Lio Corporation operates in the mechanical manufacturing and digital marketing sectors [3] Group 3 - Changjiang Securities received approval from the China Securities Regulatory Commission to issue corporate bonds totaling no more than CNY 20 billion, valid for 24 months [4] - Changjiang Securities provides services such as securities and futures brokerage, financial product distribution, investment advisory, asset custody, and margin financing [4] Group 4 - Jingye Intelligent plans to acquire 51% of Hefei Shengwen Information Technology for CNY 108 million, focusing on engineering information technology and intelligent products [5][6] - Jingye Intelligent specializes in the research, development, production, and sales of special robots and intelligent equipment systems [6] Group 5 - Aimeike's subsidiary received approval for the registration of Minoxidil topical solution, a non-prescription drug for treating hair loss [7][8] - Aimeike is engaged in the research, development, production, and sales of biomedical materials and biopharmaceuticals [8] Group 6 - Dalian Heavy Industry expects a net profit of CNY 474 million to CNY 508 million for the first three quarters of 2025, representing a year-on-year increase of 19.91% to 28.52% [9] - Dalian Heavy Industry specializes in the design, manufacturing, assembly, and installation of major technical equipment [9] Group 7 - Huayou Cobalt signed supply agreements with LGES for a total of approximately 76,000 tons of ternary precursor products from 2026 to 2030 [10][11] - Huayou Cobalt focuses on the research, manufacturing, and sales of new energy lithium battery materials and cobalt new materials [11] Group 8 - Zhenjiang Co. plans to reduce its shareholding by up to 5.529 million shares, not exceeding 3% of the total share capital, due to personal funding needs [12] - Zhenjiang Co. is involved in the design, processing, and sales of wind power equipment and components [12] Group 9 - Watson Bio's subsidiary received a drug registration certificate for a 13-valent pneumococcal polysaccharide conjugate vaccine for children [14][15] - Watson Bio specializes in the research, development, production, and sales of human vaccines and biopharmaceuticals [15] Group 10 - Yikang Pharmaceutical's major shareholder plans to reduce holdings by up to 42 million shares, not exceeding 2.04% of the total share capital, due to personal funding needs [16] - Yikang Pharmaceutical is engaged in the production and sales of excipients, raw materials, finished drugs, and new energy materials [16] Group 11 - Sichuan Gold's shareholder plans to reduce holdings by up to 7.56 million shares, accounting for 1.80% of the total share capital [19] - Sichuan Gold focuses on the construction, mining, and sales of gold mines [19] Group 12 - Kangchen Pharmaceutical received approval for a clinical trial of an innovative drug for treating advanced esophageal squamous cell carcinoma [20][21] - Kangchen Pharmaceutical specializes in the manufacturing of chemical drug formulations [21] Group 13 - UCloud plans to repurchase shares worth between CNY 8 million and CNY 10 million for employee stock ownership plans [22] - UCloud provides cloud computing services centered on IT infrastructure [22] Group 14 - Woton Technology announced an adjustment to its share repurchase plan, raising the price cap to CNY 60 per share [24] - Woton Technology specializes in the research, manufacturing, and sales of separation membrane products [24] Group 15 - Five Continents Medical announced plans for shareholders to reduce holdings by up to 126,530 shares, accounting for 1.8606% of the total share capital [26] - Five Continents Medical focuses on the research, manufacturing, and sales of disposable sterile infusion medical devices [26] Group 16 - CIMC Group plans to repurchase A-shares with a total amount not exceeding CNY 5 billion [27] - CIMC Group specializes in logistics and energy equipment solutions [27] Group 17 - Zhifei Biological's subsidiary received a drug registration certificate for a trivalent influenza vaccine suitable for individuals aged 3 and above [29][30] - Zhifei Biological is involved in the research, development, production, and sales of vaccines and biological products [30]

Group 1 - The plastic sector increased by 0.56% on September 30, with Shengquan Group leading the gains [1] - The Shanghai Composite Index closed at 3882.78, up 0.52%, while the Shenzhen Component Index closed at 13526.51, up 0.35% [1] - Shengquan Group's stock price rose by 5.74% to 33.89, with a trading volume of 380,800 shares and a transaction value of 1.278 billion yuan [1] Group 2 - The net outflow of main funds in the plastic sector was 274 million yuan, while retail investors saw a net inflow of 200 million yuan [3] - Speculative funds had a net inflow of 73.87 million yuan [3]

Core Viewpoint - The acquisition of a 51% stake in North China Plastics by Conch (Anhui) Energy-saving and Environmental Protection New Materials Co., Ltd. is a strategic move to diversify its business and address growth challenges in the PVC industry [1][2] Group 1: Acquisition Details - Conch New Materials plans to acquire North China Plastics for 95.27 million yuan, making it a subsidiary and consolidating it into the company's financial statements [1] - The acquisition reflects the company's strategy to transition from traditional PVC products to high-value polymer materials, addressing the current industry bottleneck [1][2] Group 2: Industry Context - The PVC industry is experiencing a bottleneck, with domestic inventory at 1.3005 million tons, a 1.11% increase month-on-month, and social inventory at 953,700 tons, a 2.03% increase [1] - Conch New Materials reported a revenue of 2.401 billion yuan for the first half of 2025, a 9.70% year-on-year decline, and a net loss of 28.9982 million yuan [1] Group 3: Strategic Benefits - North China Plastics specializes in high polymer low-noise rollers and modified ultra-high molecular weight polyethylene products, which complement Conch's downstream market [1] - The combination of North China Plastics' R&D capabilities and Conch's production technology can help overcome barriers to high-end products and reduce reliance on traditional PVC [2] - The acquisition is expected to create new profit growth points for Conch New Materials and alleviate losses in its main business [2] Group 4: Valuation Insights - As of July 31, 2025, the total equity value of North China Plastics was assessed at 187 million yuan, with an appraisal increment of 48.2577 million yuan, resulting in a 34.83% increase [2] - The valuation includes 5 authorized invention patents and 31 utility model patents, with a technology-related intangible asset appraisal increment of 16 million yuan [2]

Group 1 - Pingzhi Information has been selected as the eighth candidate for the "2025 China Unicom General Server Centralized Procurement Project" with a bid amount of approximately 451 million yuan [1] - The project involves the procurement of general servers primarily for cloud computing infrastructure [1] - Pingzhi Information was established in November 2002 and focuses on communication equipment, computing power, and operator equity products [1] Group 2 - Betta Pharmaceuticals has submitted an application for the issuance of H shares and listing on the Hong Kong Stock Exchange [2] - Betta Pharmaceuticals was founded in January 2003 and specializes in the production and sales of innovative drugs [2] Group 3 - Guangli Micro plans to sign an agreement with Zhejiang University to establish a joint research center for silicon photonics technology and measurement equipment [3] - The company will invest no less than 15 million yuan over three years for the center's development [3] - Guangli Micro was founded in August 2003 and provides a range of services including integrated circuit manufacturing and design [3] Group 4 - Shanhe Pharmaceutical's controlling shareholder and actual controller has changed due to the passing of Yin Zhenglong, with his wife and daughter inheriting shares [4] - After the change, Wu Changhong holds 20.172% of the total shares, while Yin Zhiya holds 6.724% [4] - Shanhe Pharmaceutical was established in April 2001 and focuses on the research, production, and sales of pharmaceutical excipients [5] Group 5 - Hengwei Technology plans to acquire 75% of Shanghai Shuhang Information Technology Co., Ltd. through a combination of share issuance and cash payment [6] - The acquisition will make Shuhang Technology a subsidiary of Hengwei Technology [6] - Hengwei Technology was founded in March 2003 and specializes in intelligent system solutions [7] Group 6 - Shougang Co. intends to repurchase its A-shares for an amount between 260 million yuan and 520 million yuan [8] - The repurchase will be used for implementing an equity incentive plan [8] - Shougang Co. was established in October 1999 and focuses on the production and sales of steel products [9] Group 7 - Pulit plans to build a 6GWh sodium-ion battery production base in Sichuan with a total investment of approximately 800 million yuan [10] - The project will be constructed in two phases, with the first phase having a capacity of 2GWh [10] - Pulit was founded in October 1999 and specializes in high polymer new materials and battery production [10] Group 8 - Saisir has proposed a cash dividend of 3.1 yuan per 10 shares for its A-share shareholders [10] - Saisir was established in May 2007 and focuses on the research, manufacturing, and sales of new energy vehicles [10] Group 9 - Guangyang Co. plans to establish a wholly-owned subsidiary for the development of precision components for robots [11] - The investment is part of a project to produce high-end components for new energy vehicles and robots [11] - Guangyang Co. was founded in April 1995 and specializes in precision components for various vehicles and equipment [11] Group 10 - Conch New Materials intends to acquire a 51% stake in North China Industrial Plastics Co., Ltd. for approximately 95.27 million yuan [12] - The acquisition will make North China Plastics a subsidiary of Conch New Materials [12] - Conch New Materials was established in October 1996 and focuses on the production and sales of plastic profiles and aluminum profiles [12] Group 11 - Daikin Heavy Industries has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [13] - The company specializes in the production and sales of offshore wind power equipment [13] - Daikin Heavy Industries was founded in September 2003 [13] Group 12 - Tengya Precision plans to invest up to 8 million USD to establish a subsidiary in Vietnam for the production of garden robots and electric tools [14] - The project will involve leasing a factory in Dong Nai Province [14] - Tengya Precision was established in August 2000 and focuses on power tools and building hardware [15] Group 13 - Luoxin Pharmaceutical plans to raise up to 207 million yuan through a private placement for innovative drug research and development [16] - The funds will primarily support clinical research for specific innovative drugs [16] - Luoxin Pharmaceutical was founded in May 1998 and specializes in pharmaceutical product development [17] Group 14 - *ST Guohua's subsidiary has become the first candidate for a project with a bid of 236 million yuan [18] - The project involves a 90-day construction period [18] - *ST Guohua was established in May 1986 and focuses on mobile network security [19] Group 15 - Su Chen Technology plans to acquire 60% of Likong Technology for a total price of 192 million yuan [20] - The acquisition will make Likong Technology a secondary subsidiary of Su Chen Technology [20] - Su Chen Technology was founded in February 2006 and specializes in CAE software development [21] Group 16 - Qingmu Technology's major shareholder plans to reduce their stake by up to 276,000 shares [22] - The reduction is due to the shareholder's financial needs [22] - Qingmu Technology was established in August 2009 and provides comprehensive e-commerce operation services [23] Group 17 - Tongda Sea plans to acquire 40% of Jiangsu Sufuda Data Technology Co., Ltd. for 25.64 million yuan [24] - The acquisition will result in Tongda Sea holding 100% of Sufuda [24] - Tongda Sea was founded in March 1995 and provides information technology services for electronic government affairs [24] Group 18 - Rongsheng Development has signed a memorandum of cooperation to promote the development of the seaplane industry [25] - The cooperation will focus on infrastructure construction and talent training [25] - Rongsheng Development was established in December 1996 and specializes in real estate development [26] Group 19 - Jinma Amusement plans to repurchase 16.52% of its subsidiary for 60 million yuan [28] - The repurchase will convert the subsidiary into a wholly-owned entity [28] - Jinma Amusement was founded in November 2007 and focuses on amusement facilities and projects [28] Group 20 - Huilv Ecology plans to acquire 49% of Junheng Technology for 1.127 billion yuan [29] - The acquisition will make Junheng Technology a wholly-owned subsidiary [29] - Huilv Ecology was established in January 1990 and specializes in optical communication products and landscape engineering [30]

Core Viewpoint - Ningbo Huaxiang announced a significant technical cooperation with Jilin University through its joint venture, acquiring a 20-year license for core patents and proprietary technology related to the industrialization of PEEK (Polyether Ether Ketone) for 30 million yuan [2] Company Summary - The joint venture, established with a registered capital of 50 million yuan, involves Ningbo Huaxiang contributing 15 million yuan, holding a 30% stake, and focusing on the research and application of PEEK materials [2] - The joint venture will employ experts from Jilin University to provide comprehensive technical services and training [2] Industry Summary - PEEK is recognized as a benchmark in the field of specialty engineering plastics, known for its high-temperature resistance, chemical corrosion resistance, mechanical strength, and excellent biocompatibility, making it widely applicable in aerospace, high-end automotive manufacturing, medical implants, and electronic information sectors [2] - The joint venture will engage in the research and trial production of PEEK materials, including polymerization, purification, modification, profile processing, and composite enhancement processes [2]

Core Viewpoint - In the third quarter, driven by the "anti-involution" trend, overall commodity prices have stopped declining and rebounded. However, polyethylene has underperformed, especially during the traditional peak season of "Golden September and Silver October," where demand did not improve significantly, leading to price declines, with prices nearing 7000 yuan/ton [1]. Group 1: Demand and Supply Dynamics - The traditional peak demand season for polyethylene, "Golden September and Silver October," has not shown significant characteristics this year, with delayed demand for agricultural films and low purchasing enthusiasm from downstream sectors [1]. - As of late September, the polyethylene operating rate was around 83%, marking a historical low for the same period, due to increased unplanned maintenance [2]. - Despite the weak demand, supply pressure has eased significantly, as there has been no new capacity impact in the second half of the year, and the overall operating rate has rebounded to around 90% in August before declining again in September [2]. Group 2: Price and Cost Factors - The cost support for polyethylene is gradually strengthening, with oil-based polyethylene experiencing losses exceeding 500 yuan/ton, while coal-based processes remain profitable [2]. - The market anticipates a potential demand surge post-National Day, with low inventory levels and the possibility of a sustained demand increase for agricultural films until late November [1][2]. - The "anti-involution" policy in the chemical sector is expected to be implemented, which may gradually change the current weak market situation for polyethylene [2].

Market Overview - The plastic sector experienced a rise of 2.93% on September 29, with Fusheng Technology leading the gains [1] - The Shanghai Composite Index closed at 3862.53, up 0.9%, while the Shenzhen Component Index closed at 13479.43, up 2.05% [1] Top Gainers in the Plastic Sector - Fusheng Technology (code: 000973) closed at 7.94, with a gain of 9.97% and a trading volume of 685,900 shares, amounting to a transaction value of 531 million [1] - Xiangyuan New Materials (code: 300980) closed at 28.14, up 8.15%, with a trading volume of 138,900 shares and a transaction value of 382 million [1] - Jinfat Technology (code: 600143) closed at 20.99, gaining 6.98% with a trading volume of 2,336,500 shares, totaling 4.777 billion [1] - Other notable gainers include Guoen Co., Changwan Wenco, and Cangzhou Mingzhu, with respective gains of 6.16%, 5.09%, and 4.60% [1] Market Capital Flow - The plastic sector saw a net inflow of 28.13 million from institutional investors, while retail investors experienced a net outflow of 50.63 million [2][3] - The main funds showed a significant net inflow into Fusheng Technology, amounting to 160 million, while retail investors had a net outflow of 104 million [3] Individual Stock Performance - Jinfat Technology had a net inflow of 62.63 million from main funds, while retail investors faced a net outflow of 48.42 million [3] - Xiangyuan New Materials also saw a net inflow of 19.31 million from main funds, with retail investors experiencing a net outflow of 12.72 million [3] - Other stocks like Dadongnan and Weike Technology also reported positive net inflows from main funds, indicating investor interest [3]

Core Viewpoint - The report highlights significant target price increases for several listed companies from September 22 to September 28, indicating potential investment opportunities in the software development, plastics, and passenger vehicle sectors [1][2]. Group 1: Target Price Increases - The companies with the highest target price increases include: - Gaweida (高伟达) with a target price increase of 123.43% [2] - Dongcai Technology (东材科技) with a target price increase of 59.60% [2] - SAIC Motor (上汽集团) with a target price increase of 54.05% [2] - Other notable companies with significant target price increases include: - Hengrui Medicine (恒瑞医药) at 47.27% [2] - Shenling Environment (申菱环境) at 46.59% [2] - Yifeng Pharmacy (益丰药房) at 45.04% [2] Group 2: Broker Recommendations - A total of 366 listed companies received broker recommendations during the same period, with notable mentions: - Tianshili (天士力) received recommendations from 6 brokers [3] - Wanwei High-tech (皖维高新) received recommendations from 3 brokers [3] - Yinlun Shares (银轮股份) also received recommendations from 3 brokers [3] Group 3: Rating Adjustments - There were 14 instances of rating upgrades, including: - Yunding Technology (云鼎科技) upgraded from "Hold" to "Buy" by Dongbei Securities [6] - Landai Technology (蓝黛科技) upgraded from "Hold" to "Buy" by Caitong Securities [6] - Jiasheng Group (健盛集团) upgraded from "Hold" to "Buy" by CITIC Securities [6] - Conversely, 6 instances of rating downgrades were noted, including: - Binglun Environment (冰轮环境) downgraded from "Strong Buy" to "Buy" by Founder Securities [7] - Kuncai Technology (坤彩科技) downgraded from "Buy" to "Hold" by CITIC Securities [7] Group 4: First Coverage - During the same period, 115 instances of first coverage were reported, with companies such as: - Tongling Nonferrous Metals (铜陵有色) receiving a "Buy" rating from Western Securities [8] - Lifan Pharmaceutical (立方制药) also receiving a "Buy" rating from Western Securities [8] - Xinjiang Zhonghe (新疆众和) receiving an "Increase" rating from Shenwan Hongyuan Group [8]